344338-13-2Relevant articles and documents
5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Page/Page column 90-91; 92; 73, (2021/04/17)
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS
-
Paragraph 00190, (2020/03/02)
The present invention provides compounds of Formula (I): useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
SUBSTITUTED 5-CYANOINDOLE COMPOUNDS AND USES THEREOF
-
Paragraph 00274; 00348, (2019/01/10)
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders, Formula (I), wherein R1, R2, R3, R4, and R5 are as defined herein.